SLA - Solagran Limited

[tugga]

News around the corner

Can't be much longer, well god I hope so because I did a silly thing like get a CASH ADVANCE waiting for good news....

What a dumb ass move

 

[So_Cynical]

So whats with the SP down trend since July?...everything seems to be going OK :dunno:


Market Cap.....119,953,055
Issued Shares..131,816,545
52-wk High......1.55
52-wk Low......0.61

 

[rub92me]

With a 100 million market cap and little cash, a lot of potential is already reflected in the price imho. If/when they can prove they can produce an annual profit of >10 million it will be a different ballgame. Watching, but not thinking about entering just yet.

 

[tugga]

Once they show us they can make money then this baby will shoot off.

I'm averaging at 86c

Been in for over a year now.

 

[BIG BWACULL]

Announcement out, Maybe dollars to flow this year

Company Announcement
Regulators Release Ropren ®for Sale in Russia

On 28 February 2008, Solagran announced to the ASX that Russian regulatory authorities
were expected to release its new prescription pharmaceutical Ropren ® for sale in the
Russian market within 1 to 1.5 months. The Directors of Solagran are pleased to announce
that this final administrative formality was completed sooner than expected and the official
release to market has now been received.
Solagran’s manufacturing partner Galenopharm is now free to commence production of
Ropren ® for sale throughout Russia. Solagran is hopeful that initial production volumes will
be sufficient to meet the needs of the main population centres of Moscow and St Petersburg.
Solagran will now turn its attention to ensuring that it is in a position to respond effectively to
the significant world wide interest in this product. A plant containing the world’s first
commercial polyprenols production facility is due to be opened by the Governor of the Tomsk
Region, Mr Victor Kress, at 3.00pm tomorrow local time. When operating at full capacity, this
facility will generate sufficient polyprenols (Bioeffective ® R) to produce 50-60,000 courses of
Ropren ® per annum.
Coming together in the same week, these two events constitute a really major milestone for
the company. They mark the beginning of Solagran’s transition from a research-focussed
biotechnology company into an important player in the international natural pharmaceuticals
market.
The Russian pharmaceutical registration process is structured in such a way that approval of
a new prescription medicine should take 6-7 years after the successful completion of phased
clinical trials. Ropren ® has passed the entire regulatory approval process in just 4 years
and 1 month from the receipt of Ministry of Health approval to conduct clinical trials in
February 2004. This is an outstanding achievement, and a testament to both the efficacy
and the safety of Ropren ®.
The Board wishes to express its appreciation for the efforts of all personnel involved.

 

[BIG BWACULL]

Nice move today after that announcement up 27c or 33% on volume of 553,962 heh heh now i'm smilin ROPREN Anyone :

 

[urgalzmine]

Hey Everyone

As you all know I am very new to all this (shares ), I have been doing some reading on announcements for this company and I like what I read.

This drug Ropen or Bioeffectives R cures liver disease to assisting cures for cancer. Please hear this announcement
http://www.brr.com.au/event/39959 for the range of cures for this drug.

They just got approvals to distribute and sell the product within Russia and they have done human trials in Russia as well as in Australia.

The only thing left is to obtain a patent for the product, without this SLA only become the distributor of ingredients to make the product ROPEN which is not worth while.

According to executive director on board room radio(refer to above link), Mr Denis Kilroy he is hoping to sell the product for $5000 per course.

If you review the latest announcement on the 19/03/08 http://imagesignal.comsec.com.au/asxdata/20080319/pdf/00824814.pdf

It indicates that they are hoping to produce 50 - 60000 course of Ropen per annum. Therefore:

50000 course * $5000 per course potentially = 10.7 Billion per year.
MC = 105Million

However SLA are looking to give a discount to Russians first, but no price. I also cannot find if they have got approvals for their patent. Obviously this is still a speculative stock as production is in Russia

There is still along way to go to release to the market but if successful this stock could be very big. :

Please correct me if I have read any of this incorrectly?

 

[HOMER J]

Hey Everyone



The only thing left is to obtain a patent for the product, without this SLA only become the distributor of ingredients to make the product ROPEN which is not worth while.

no, they can make and sell the finished product (ropren) as of today when their plant opens. they have many patents stitched up already. the most recent one applied for just covers some improvements to their extraction methods etc.

you might want to re-check you calculations too.
(most guess between $1000 - $4000 for ropren pricing in russia but we dont know yet).

here is a research report on sla that is worth a read, keep in mind its 6 months old and since then ropren has now been completely approved for sale...

http://www.solagran.com/documents/SOL_RMR_29_10_07.pdf

cheers







my opinion only, not investment advise etc etc...

 

[urgalzmine]

lol..

Ahh thanks Homer 50000 * $5000 = $250mill

LOL i got a little head of myself, to many zeros..., still thats pretty good

thanks homer for the PDF that was awesome

 

[HOMER J]

No worries, if you look through past announcements you will see management are predicting sales to grow to around 1.3 million courses by 2013, which at anything above $1000 a course will be a massive amount of money coming into solagran

cheers







my opinion only, not investment advise etc etc...

 

[urgalzmine]

Well it doesnt look to flash at the moment with this OP broker going bust. It looks like ANZ will be taking over all of the directors shares.


THis is not looking too good at all.... I thought that i would be worried about russian politics/economy, looks like I should be looking in my own backyard...

Sorry if I sound negative about this, but can someone advise of any upside on this?

 

[TheAbyss]

Given that ANZ have 42% of SLA now we can only hope that an off market deal takes place. SLA have proven themselves so the chances are good that one of the business partners take sa larger stake, the directoprs have funds available to buy their stake back or a knight will show up.

Down 17% today on low volumes. I dont have many so a wait and see approach will work for me.

 

[rhombus]

what a circus!

everything just seems to be going wrong now.

Solagran may face ASIC

Reuters

Melbourne-based biotechnology company Solagran may be referred to financial regulators after it was revealed it had not disclosed the full extent of directors' exposure to failed broker Opes Prime, reports The Age.

Last night, Solagran released a statement saying it had 'fully complied' with the Australian Securities Exchange's (ASX) disclosure regulations, arguing that its Opes Prime shareholding was not 'material.'

The ASX said it would review Solagran's response. Solagran bought about 4 million shares through Opes Prime in the last nine months of 2007, reports The Age.

 

[unit]

Solagran thread gone quiet for a while with so much going on.
When can some of the issues expected to be resolved and what are favourable or unfavourable outcomes?

 

[rhombus]

massive massive volume yesterday. 8.5 mill. think that would be the ANZ offloading? would make sense i guess. someone at SLA must be buying them back. was expecting a bit of a move today but not much so far.

 

[urgalzmine]

massive massive volume yesterday. 8.5 mill. think that would be the ANZ offloading? would make sense i guess. someone at SLA must be buying them back. was expecting a bit of a move today but not much so far.

Well even though the directors got screwed with the Opes Prime debacle, i really hope they start focusing on Ropren instead of legal battles, the sooner ANZ sell all their shares the better..

 

[NoIdea]

I noticed another 8.8 mil shares traded this morning which can only be ANZ doing another dump. On rough estimates IMO, ANZ must be down to 38+mil shares to go.

The site announced changes in director holdings today (which would be for the last lot of trades) so I can only imagine the directors are buying up big again.

Now if this is the case and with no news in the market place on how the are going with the production and sales (I read in the past they are good at holding information), my only belief would be things must be going ok in Russia.

Hanging out for the next quarterly financial figures, one can only stay optimistic .

 

[NoIdea]

Finally some news (yesterday's announcement) on what has been going on from Russia. Obviously, with the Opes Prime debacle things slow a little but I'm glad to read it's all full steam ahead again.

I notice that ANZ had now sold down to 30 million (announcements have not been made but another 8 million yesterday and I'm expecting an announcement today on the 8 million sold from last week) which is half of what they started.

Can't wait for the full report around the 13th of this month, it's almost time to get really excited about Ropren (BioEffective R).

 

[NoIdea]

ANZ No more. Waiting on the business plan announcement from the company which I'm hoping will get everyone excited. Go SP go!

 

[NoIdea]

For all the faithful, maybe it's only myself. May Ropren saves us forever.

SP on the go.

Where is the business plan from the company?